Concepedia

Author

J. van der Lelie

University of Amsterdam

Also Known As

J Van der Lelie, J van der Lelie, J. Lelie, J. V. D. Lelie, J. Van Der Lelie, J. v.d. Lelie, J. van der Lelie, Johannes Van Der Lelie, Johannes Van der Lelie, Johannes van der Lelie

56

Publications

2.3K

Citations

20

H-Index

70

Concepts

All Affiliations

University of AmsterdamAmsterdam UMC Location University of AmsterdamDutch Blood Transfusion SocietyVrije Universiteit AmsterdamRotterdam University of Applied Sciences
JV

About

J. van der Lelie is an author at University of Amsterdam specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

21

1.1K

2

Health Sciences

7

7

372

3

Public Health

2

2

308

4

Nursing

1

1

294

5

Allergy

1

1

94

J. van der Lelie

×

27

Publications

2.2K

Citations

20

H-Index

YearCitations

Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

Dimitri Breems, Wim L.J. van Putten, Peter C. Huijgens,

Journal of Clinical Oncology

2005

510

Cancer, fatigue and the return of patients to work—a prospective cohort study

Evelien Spelten, Jos Verbeek, A. L. J. Uitterhoeve,

European Journal of Cancer

2003

294

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud,

Journal of Clinical Oncology

1998

288

Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study.

Bob Löwenberg, Leo Verdonck, AW Dekker,

Journal of Clinical Oncology

1990

135

Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

Bob Löwenberg, M. Boogaerts, Simon Daenen,

Journal of Clinical Oncology

1997

128

Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection

J. van der Lelie, Joep M. A. Lange, J. J. E. Vos,

British Journal of Haematology

1987

94

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

Pieter Sonneveld, Stefan Suciu, P. Weijermans,

British Journal of Haematology

2001

93

Increased mean platelet volume in septicaemia.

J. van der Lelie, AEG Kr von dem Borne

Journal of Clinical Pathology

1983

88

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato‐Oncology Co‐operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Dimitri Breems, Marc Boogaerts, A. W. Dekker,

British Journal of Haematology

2004

74

Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.

A. W. Dekker, Mars B. vanʼt Veer, W Sizoo,

Journal of Clinical Oncology

1997

72

Page 1